A revised classification for Leishmania and Endotrypanum, Parasitol Today, vol.16, p.10725899, 2000. ,
, Visceral leishmaniasis in Algeria: study of cases hospitalized between, 1975.
, Ann Soc Belg Med Trop, vol.65, pp.329-335, 1985.
, Leishmania infantum MON-1 isolated from Phlebotomus perniciosus
, Ann Parasitol Hum Comp, vol.65, pp.151-152, 1990.
Epidemiology of leishmaniasis in Algeria. 6. Survey of clinical cases of infantile visceral leishmaniasis from, 1965. ,
, Bull Soc Pathol Exot, vol.69, pp.68-75, 1976.
Two autochthonous cases of general leishmaniasis (mediterranean kala-azar) observed at Hoggar ,
, Arch Institut Pasteur d'Algérie, vol.34, pp.370-379, 1956.
Three new autochthonous cases of general leishmaniasis (Mediterranean kala-azar) observed at Hoggar (Central Sahara) ,
, Arch Institut Pasteur d'Algérie, vol.35, pp.204-211, 1957.
,
, Bull Soc Pathol Exot, vol.78, pp.615-622, 1985.
,
, Bull Soc Pathol Exot, vol.85, pp.296-301, 1992.
É tude de 71 cas de leishmaniose viscérale diagnostiqués au CHU Mustapha d'Alger entre, Médecine Mal Infect, vol.42, pp.119-125, 1998. ,
Epidemiology of visceral leishmaniasis in Algeria: An Update, PLoS One, vol.9, pp.28-99207, 2014. ,
Description of a dermatropic Leishmania close to L. killicki (Rioux, Lanotte and Pratlong, 1986) in Algeria, Trans R Soc Trop Med Hyg, vol.103, pp.716-720, 2009. ,
Cutaneous leishmaniasis in North Africa: a review, Parasite, vol.21, p.14, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01098542
Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains, Trop Med Int Health, vol.14, pp.1071-1085, 2009. ,
,
, Bull Soc Pathol Exot, vol.105, pp.30-35, 2012.
Isolation of Leishmania major Yakimoff & Schokhor, 1914 from Psammomys obesus Gretzschmar, 1828 (Rodentia: Gerbillidae) in Algeria, Trans R Soc Trop Med Hyg, vol.77, p.876, 1983. ,
Découverte d'un Meriones shawi (Rongeur, gerbillidé) naturellement infesté par Leishmania dans le nouveau foyer de leishmaniose cutanée de Ksar Chellala (Algérie), Bull Soc Pathol Exot, vol.79, pp.630-633, 1986. ,
Isolation of Leishmania major from Phlebotomus papatasi in Biskra. The end of an ecoepidemiological saga ,
, Ann Parasitol Hum Comp, vol.67, pp.31-32, 1992.
Phlebotomus (Larroussius) perfiliewi naturally infected with dermotropic Leishmania infantum at Tenes, Algeria, Trans R Soc Trop Med Hyg, vol.22, p.399, 1993. ,
,
, Med Trop, vol.64, pp.381-383, 2004.
Cutaneous leishmaniasis caused by Leishmania killicki, Algeria. Emerg Infect Dis, vol.20, pp.502-504, 2014. ,
Phlebotomus sergenti (Parrot, 1917) identified as Leishmania killicki host in Ghardaïa, south Algeria Microbes Infect, vol.13, pp.691-696, 2011. ,
Canine leishmaniasis: epidemiological risk and the experimental model, Trends Parasitol, vol.18, pp.399-405, 2002. ,
Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons, J Clin Microbiol, vol.44, pp.1318-1322, 2006. ,
Leishmania antimony resistance: what we know what we can learn from the field, Parasitol Res, vol.109, p.21800124, 2011. ,
, Trans R Soc Trop Med Hyg, vol.90, issue.96, pp.90410-90411, 1996.
Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria, Trans R Soc Trop Med Hyg, vol.80, pp.670-671, 1986. ,
Prise en charge de la leishmaniose cutanée en Algérie, Med Mal, vol.43, 2013. ,
Drug regimens for visceral leishmaniasis in Mediterranean countries, Trop Med Int Health, vol.13, p.18764817, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375214
In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure, Vet Parasitol, vol.187, pp.386-393, 2012. ,
Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials, Infect Immun, vol.77, pp.2022-2029, 2009. ,
In vitro anti-Leishmanial activity of compounds in current clinical use for unrelated diseases, Drugs Exp Clin Res, vol.14, pp.621-628, 1988. ,
Canine Leishmania infantum enzymatic polymorphism: a review including 1023 strains of the Mediterranean area, with special reference to Algeria, Acta Trop, vol.118, pp.80-86, 2011. ,
Leishmania infantum and L. major in Algeria, Trans R Soc Trop Med Hyg, vol.90, pp.625-629, 1996. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00605364
Use of isoenzymes. Suggestions for a new classification, Ann Parasitol Hum Comp, vol.65, pp.111-125, 1990. ,
Leishmania donovani: intraspecific polymorphisms of Sudanese isolates revealed by PCR-based analyses and DNA sequencing, Exp Parasitol, vol.97, pp.35-44, 2001. ,
Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas, Acta Trop, vol.80, pp.195-205, 2001. ,
Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83, Parasitol Res, vol.100, p.17096142, 2007. ,
Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei in a semi-defined medium, Acta Trop, vol.36, pp.289-292, 1979. ,
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1, Acta Trop, vol.51, pp.237-245, 1992. ,
Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization, PLoS One, vol.7, pp.1-7, 2012. ,
The increase in risk factors for leishmaniasis worldwide, Trans R Soc Trop Med Hyg, vol.95, pp.239-243, 2001. ,
Risk factors in the spread of leishmaniases: towards integrated monitoring?, Trends Parasitol, vol.22, pp.4-6, 2006. ,
Current epidemiological data on visceral leishmaniasis in Tunisia, Med Mal infect, vol.39, pp.775-779, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00684000
Leishmaniases in Maghreb: an endemic neglected disease, Acta Trop, vol.132, pp.80-93, 2014. ,
Identification of the causative agent of cutaneous leishmaniasis in Chichaoua province, Morocco. Parasite, vol.19, pp.81-84, 2012. ,
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites, PLoS Med, vol.3, 2006. ,
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs, Exp Parasitol, vol.135, pp.36-41, 2013. ,
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the Western Mediterranean, vol.58, pp.4866-4874, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01060243
Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis, Southeast Asian J Trop Med Public Health, vol.42, pp.502-508, 2011. ,
Comparison of agar dilution, broth dilution, cylinder plate and disk diffusion methods for evaluation of anti-leishmanial drugs on Leishmania promastigotes, Iran J Parasitol, vol.7, pp.43-47, 2012. ,
Semiautomated assessment of in vitro activity of potential antileishmanial drugs, Antimicrob Agents Chemother, vol.28, pp.723-726, 1985. ,
In Vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells. Antimicrob Agents Chemother, vol.53, pp.5197-5203, 2009. ,
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent, J Antimicrob Chemother, vol.65, pp.508-511, 2010. ,
A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit, PLoS Negl Trop Dis, vol.5, 2011. ,
Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: impact on in vitro parasite developmental cycle and metabolic enzyme activities, Infect Genet Evol, vol.6, pp.187-197, 2006. ,
Advances and perspectives in Leishmania cell based drug-screening procedures, Parasitol Int, vol.56, pp.3-7, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00376733
A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations, Cell Microbiol, vol.13, p.20846338, 2011. ,
Imaging Leishmania development in their host cells, Trends Parasitol, vol.25, pp.464-473, 2009. ,
Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum, Clin Infect Dis, vol.48, pp.16-22, 2009. ,
Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum, Am J Trop Med Hyg, vol.71, pp.71-72, 2004. ,
In vitro cultivation and characterization of axenic amastigotes of Leishmania, Trends Parasitol, vol.17, pp.150-153, 2001. ,
Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents, Antimicrob Agents Chemother, vol.41, pp.972-976, 1997. ,
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum, Acta Trop, vol.74, pp.25-31, 2000. ,
American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility?, J Infect Dis, vol.194, pp.1168-1175, 2006. ,
Treatment of visceral leishmaniasis, Med Microbiol Immunol, vol.190, pp.89-103, 2001. ,
In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences, Antimicrob Agents Chemother, vol.53, pp.3855-3859, 2009. ,
A Proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death, Mol Cell Prot, pp.88-101, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00170702
Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1, Biochem J, vol.381, pp.405-412, 2004. ,
Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug Pentostam, J Biol Chem, vol.279, pp.37445-37451, 2004. ,
, Antimicrobial resistance: global report on surveillance, WHO, 2014.
Antimony resistance and environment: elusive links to explore during Leishmania life cycle, Int J Parasitol: Drugs & Drugs Resistance, vol.2, pp.200-203, 2012. ,